32817937 |
The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitro
Chaparian, RR,
Bulaon, DK,
Anand, SK,
Johnson, JL,
Shobana-Ganesh, K,
Trimarco, JD,
Liberatore, KM,
Levy, TM,
Nilsson-Payant, BE,
Getz, G,
Beausoleil, SA,
Weinstein, H,
Tata, PR,
Kavanagh-Williamson, M,
Matthews, D,
Yaron, TM,
Chen, SB,
Lee, G,
Kerelsky, A,
Lin, TY,
Heesom, K,
Cohen, BM,
Mercadante, MN,
Blenis, J,
Possemato, AP,
Zhu, X,
Tkachev, SL,
Hamele, CE,
Piskounova, E,
Smith, CM,
Davidson, AD,
Harding, AT,
He, L,
Heaton, BE,
Jordan, TX,
Burke, KN,
Cantley, LC,
Kastenhuber, ER,
tenOever, BR,
Tata, A,
Aguet, F,
Elemento, O,
Hornbeck, PV,
Schwartz, RE,
Heaton, NS
|
bioRxiv |
2020 |